Hyundai joins hands with French firm Air Liquide for ventilator production

As part of the partnership, Hyundai and ALMS are looking to produce 1,000 ventilators in the first phase, and to scale up subsequently.

PTI

April 18, 2020 / 13:36 IST

Representative image

Hyundai Motor India on Saturday said it has tied up with French company Air Liquide Medical Systems (ALMS) for production and supply of ventilators in Tamil Nadu and other states. France-based ALMS is present in India through a subsidiary which is based out of Chennai.

As part of the partnership, Hyundai and ALMS are looking to produce 1,000 ventilators in the first phase, and to scale up subsequently.

"Ventilators and other respiratory aids are critical devices in the fight against COVID-19 and to this end, Hyundai and ALMS are working together to ensure a steady supply of ventilators in India," Hyundai Motor India MD and CEO S S Kim said in a statement.

Coronavirus India News LIVE Updates

ALMS India Managing Director Anil Kumar said the company has initiated a prompt response towards the fight against COVID-19 in support of the government.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show